Want to join the conversation?
$PRGO, which competes with $AGN, said its Rx pipeline is strong and it expects greater than $5.5Bil in prescription brand sales over the next three years. The company has 25 ANDAs pending FDA approval, 5 Paragraph IV litigations, and 6 projects in clinical studies.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)
$AGIO plunge 15%.. what's happening... is this going for a toss !
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.